Hangzhou, China · Founded 2019 · Privately Held (backing)
Developer of pulmonary therapy medication intended to be used for the perioperative period. Cuize Medicine is based in Hangzhou, China and was founded in 2019. Its last reported valuation was $83.4 million in Jun 2025. It has raised $12.6 million.
Last reported valuation
$83.4M
Oct 2026
Priced at
—
Total raised
$12.6M
Last round
—
Cap table — not yet on record
Cuize Medicine's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cuize Medicine with a free account
·Watch Cuize Medicine: the Monday email on marks, rounds and moves
